Follow Building in Public Podcast: https://x.com/builtnpublicpod
In this episode, Aldo de Pape, the founder of GenomesDAO, discussed the challenges facing the genetic testing industry and how his organization is addressing them. He highlighted concerns around privacy and security, particularly in light of the increasing number of healthcare data breaches. GenomesDAO's approach prioritizes the safety and ownership of genomic data, contrasting their model with companies like 23andMe by ensuring individuals retain control over their biological samples and data via blockchain technology and partnerships with companies like AMD. Aldo also explained how GenomesDAO’s consent protocol allows individuals to be compensated for sharing their data with research partners, such as pharmaceutical companies. He discussed the value of genomic data and the ways users can engage with the platform, either by ordering a genetic testing kit or transferring data from other platforms. The episode also covered the demand side of GenomesDAO's business model, where the platform serves as secure infrastructure for genomic research, with growing interest from pharmaceutical companies. Through its focus on data ownership, security, and user empowerment, GenomesDAO is reshaping the genetic testing landscape.
Timestamps:
00:00 - Introduction
00:32 - Genomic Data and Privacy Concerns
02:20 - Challenges in the Genetic Testing Industry
03:58 - GenomesDAO's Mission and Approach
04:18 - Security Measures Compared to Traditional Companies
07:39 - Monetization and Data Ownership Issues
08:27 - Consent and User Engagement
10:42 - Getting Involved with GenomesDAO
12:21 - Point System and Health Reports
18:13 - Token Launch and Blockchain Details
19:13 - Building on BASE and Ecosystem Synergies
20:58 - Demand Side and Research Partnerships
25:08 - Conclusion
Disclaimer: The hosts and the firms they represent may hold stakes in the companies mentioned in this podcast. None of this is financial advice.
Remember Everything You Learn from Podcasts
